Skip to main content
Market Cap
$706.91M
Shares
51.23M

No Price Data

No daily price data is available for this stock yet. Data syncs automatically from Yahoo Finance.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 7, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Limited Momentum Limited Sentiment Neutral Fundamentals Strong Quant / Vol Limited
Market backdrop VIX 15.2 · calm Equity put/call 0.60
Technical
price trend
Limited
Not enough data for a confident read.
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
33 of 174 funds reported for Jun 30 · net -1.2M sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.27% of float · ▼ -88.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
174 holders — mid 3-yr range
Fundamentals
Strong
Revenue growth +2%
Y/Y
EPS growth +97%
Y/Y
Free cash flow $65.8M
Balance sheet $382.4M
net debt
Quant / Vol
risk profile
Limited
Not enough data for a confident read.

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 1 of last 2
Latest guidance · from the Earnings Call filed Jun 30, 2025
Full year revenue · full year Initiated $1.06B – $1.07B
prior FY $1.06B midpoint +0.6% Y/Y
Adjusted free cash flow · full year Non-GAAP Initiated $47M – $57M
Adjusted EBITDA · full year Non-GAAP Initiated $104M – $108M
Guided vs delivered · last 2 settled
Full year revenue full year
guided $1.06B – $1.07B
$1.06B In line
Net service revenue full-year 2024
guided $1.06B – $1.06B
$1.03B Miss −2.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings
Metric Latest Period YoY
Adjusted diluted EPS non-GAAP $0.14 Q4
Adjusted EBITDA margin non-GAAP 10.4% Q4
Cost per patient day (Home health) $27.8 Q4
Cost per visit (Home health) $102 Q4
De novo locations opened 4 Q4
Home health cost per patient day change -3.5% Q4
Home health year-over-year admissions growth 7.3% Q4
Hospice ADC growth 9.9% Q4
Hospice Adjusted EBITDA growth non-GAAP 2.3% Q4
Hospice admissions growth 0.8% Q4
Hospice cost per patient day change 0.6% Q4
Leverage ratio 3.7 Q4
Medicare ADC sequential decline -1.7% Q4
Medicare admissions (Home health) 22,196 Q4
Medicare average daily census (Home health) 19,030 Q4
Medicare completed episodes (Home health) 38,077 Q4
Medicare recertifications (Home health) 15,203 Q4
Medicare visits (Home health) 490,281 Q4
Non-Medicare admissions (Home health) 34,582 Q4
Non-Medicare average daily census (Home health) 23,294 Q4
Non-Medicare recertifications (Home health) 14,840 Q4
Non-Medicare visits (Home health) 574,023 Q4
Revenue per episode (Medicare, Home health) $2,931 Q4
Revenue per patient day (Home health) $53.1 Q4
Same-store total admissions growth (Home health) 7.2% Q4
Same-store total recertifications growth (Home health) 0.7% Q4
Segment Adjusted EBITDA margin (Home health) non-GAAP 17.9% Q4
Total admissions (Home health) 56,778 Q4
Total average daily census (Home health) 42,324 Q4
Total recertifications (Home health) 30,043 Q4
Total visits (Home health) 1,064,304 Q4
Visits per episode (Medicare, Home health) 12.9 Q4
Visits per episode (Total, Home health) 12.5 Q4

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EHAB
Enhabit, Inc.
this stock
$706.91M -2.3% 0.3%
HCA
HCA Healthcare, Inc.
$90.71B -11.9% +7.1% 14.1 2.6%
FSNUY
Fresenius SE & Co. KGaA
$30.50B -2.4% 0.0%
THC
Tenet Healthcare Corp
$21.08B +31.7% -2.3% 10.1 3.7%
FMS
Fresenius Medical Care AG
$12.83B +4.3% 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
142
% held
92.4%
Reported
33 of 174
Top holder
DEERFIELD MANAGEMENT COMP…
Held Float
View
Held by Funds
Fund positions
135
View
Short & Settlement
Short Interest Falling
Shares short
139.8K
Days to cover
1.0d
Change
-1.1M sh
View
Short Volume
Short vol %
63%
As of
May 14, 2026
Short Total
View
Fails to Deliver
FTD shares
264
Value
$3.6K
As of
May 18, 2026
View
Financials
Financials
Revenue (FY)
$1.1B
Net income (FY)
$-4.6M
EPS diluted
$-0.09
View
Filings
SEC Filings
Latest
8-K
Filed
May 15, 2026
This year
12
View
Proposed Sales
Value
$19.1K
Shares
1.4K
Filed
Mar 11, 2026
View
Earnings & Events
Earnings Calls
Last call
Mar 5, 2026
View
Key facts CIK 1803737 CUSIP 29332G102 13F (30d) 1 filings 1 filers Visit website